S-600918, Sivopixant
Nkọwa ngwaahịa
Mkpado ngwaahịa
Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
Aha kemịkalụ:
(2S)-3-[(4E) -3-[(4-chlorophenyl)methyl]-2,6-dioxo-4-({4-[(pyridin-2-yl) oxy]phenyl}imino) -1 ,3,5-triazinan-1-yl] -2-methylpropanoic acid
Koodu Ọchịchọ:
O=C(O)[C@@H](C)CN1C(N(CC2=CC=C(Cl)C=C2)/C(NC1=O)=N/C3=CC=C(OC4=NC) =CC=C4)C=C3)=O
Koodu InChi:
InChI=1S/C25H22ClN5O5/c1-16(22(32)33)14-31-24(34)29-23(30(25(31)35)15-17-5-7-18(26)8- 6-17)28-19-9-11-20 (12-10-19)36-21-4-2-3-13-27-21/h2-13,16H,14-15H2,1H3,(H ,32,33)(H,28,29,34)/t16-/m0/s1
Igodo InChi:
SKZQFKBIJUXXCG-INIZCTEOSA-N
Okwu:
2414285-40-6; CAS: 2414285-40-6; CAS: 2414285-40-6; Sivopixant; S-600918; S 600918; S600918
Solubility:Soluble na DMSO
Nchekwa:Akọrọ, ọchịchịrị na na 0 - 4 C maka obere oge (ụbọchị ruo izu) ma ọ bụ -20 C maka ogologo oge (ọnwa ruo afọ)
Nkọwa:
Sivopixant, nke a makwaara dị ka S-600918, bụ onye na-anabata P2X3 antagonist (P2X3 IC50, 4.2 nM; P2X2/3 IC50, 1100 nM). Sivopixant gosipụtara mmetụta analgesic siri ike na oke akụkụ akụkụ sciatic nerve ligation model (Seltzer model) nke allodynia (ED50, 0.4 mg / kg).
Ebumnuche: Nhọrọ P2X3 antagonist anabata